| |
| |
|
| Insider
Information: |
Fitzgerald Joseph Michael |
| Relationship: |
EVP & Group Pres, Card... |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
190,487 |
|
|
Indirect Shares
|
4,894 |
|
|
| Direct
Value |
$14,219,855 |
|
|
|
Indirect Value
|
$365,337 |
|
|
| Total
Shares |
195,381 |
|
|
| Total
Value |
$14,585,192 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Boston Scientific Corp |
BSX |
EVP & Group Pres, Card... |
2024-05-13 |
190,487 |
2024-05-13 |
4,894 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2019-12-13 |
4 |
OE |
$7.41 |
$797,998 |
D/D |
107,692 |
308,377 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2019-12-13 |
4 |
AS |
$45.00 |
$4,846,140 |
D/D |
(107,692) |
200,685 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Interven Cardio |
• • – |
2021-07-27 |
4 |
AS |
$45.00 |
$4,747,377 |
D/D |
(105,490) |
203,596 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2018-02-07 |
4 |
AS |
$26.48 |
$2,256,675 |
D/D |
(85,227) |
151,925 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2018-02-07 |
4 |
OE |
$12.52 |
$1,067,042 |
D/D |
85,227 |
237,152 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-12-29 |
4 |
AS |
$57.50 |
$4,711,550 |
D/D |
(81,940) |
174,241 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2016-05-03 |
4 |
S |
$21.81 |
$1,743,536 |
D/D |
(79,960) |
92,020 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2022-12-13 |
4 |
AS |
$47.78 |
$3,787,234 |
D/D |
(79,264) |
216,871 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2022-12-13 |
4 |
OE |
$7.39 |
$585,761 |
D/D |
79,264 |
296,135 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Interven Cardio |
• • – |
2020-09-11 |
4 |
OE |
$7.16 |
$555,902 |
D/D |
77,640 |
298,688 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Interven Cardio |
• • – |
2020-09-11 |
4 |
AS |
$40.76 |
$3,164,653 |
D/D |
(77,640) |
221,048 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & Pres, Interven Cardio |
• • – |
2021-07-27 |
4 |
OE |
$6.28 |
$441,522 |
D/D |
70,306 |
309,086 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2024-02-20 |
4 |
D |
$66.22 |
$4,501,238 |
I/I |
(67,974) |
0 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-05-16 |
4 |
AS |
$53.60 |
$3,394,856 |
D/D |
(63,339) |
213,859 |
0 |
% |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2015-02-10 |
4 |
S |
$14.66 |
$897,450 |
D/D |
(61,208) |
84,379 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2016-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
60,892 |
185,015 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-12-29 |
4 |
OE |
$16.31 |
$949,063 |
D/D |
58,189 |
256,181 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & Group Pres, Cardiology |
• • – |
2023-05-16 |
4 |
OE |
$13.08 |
$744,527 |
D/D |
56,921 |
277,198 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
47,782 |
159,970 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
47,174 |
134,689 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2019-02-12 |
4 |
AS |
$40.00 |
$1,769,440 |
D/D |
(44,236) |
197,940 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2019-02-12 |
4 |
OE |
$8.30 |
$367,159 |
D/D |
44,236 |
242,176 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
41,384 |
193,309 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, Rhythm Mgmt |
• • – |
2019-02-20 |
4 |
A |
$0.00 |
$0 |
D/D |
40,556 |
237,346 |
0 |
- |
|
| BSX |
Boston Scientific Corp |
EVP & President, CRM |
• • – |
2015-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
38,814 |
158,966 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
